| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +562.2% |
| R&D Expense | $17.9M | +9.9% |
| SG&A Expense | $15.7M | +2.4% |
| Operating Income | -$32.0M | -2.2% |
| Pre-tax Income | -$31.1M | -0.0% |
| Income Tax | -$13K | +98.0% |
| Net Income | -$31.1M | -2.1% |
| EPS (Basic) | -$3.71 | -1.6% |
| EPS (Diluted) | -$3.71 | -1.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.0M | -40.9% |
| Short-term Investments | $11.4M | — |
| Current Assets | $72.0M | -27.8% |
| Total Assets | $72.3M | -27.9% |
| Current Liabilities | $6.7M | +30.8% |
| Total Liabilities | $12.7M | +12.1% |
| Stockholders' Equity | $59.6M | -33.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.6M | +10.2% |
| Investing Cash Flow | -$11.4M | -143.7% |
| Financing Cash Flow | -$821K | -327.6% |